Impact of nutritional status on chemotherapy delivery and outcomes in advanced pancreatic cancer: A prospective multicenter study
Clinical Nutrition · 2026
DOI: 10.1016/j.clnu.2025.106573 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Nutrition, 2026. Verfasst von Maria Kiriukova und 18 weiteren Autor:innen. Beteiligte Einrichtung: Pancreatic, Biliary, and Upper GI Diseases, A.S. Loginov Moscow Clinical Research Center, Russia. Hauptthemen laut MEDLINE: Antineoplastic Agents, Carcinoma, Pancreatic Ductal, Malnutrition, Nutritional Status. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Ministry of Health, Associazione Italiana per la Ricerca sul Cancro.
Themen: Mangelernährung, Onkologische Pflege
Abstract (Originalsprache)
BACKGROUND & AIM: Malnutrition is common in pancreatic ductal adenocarcinoma (PDAC) and may compromise chemotherapy delivery. We investigated whether baseline nutritional status and quality of life (QoL) predict chemotherapy relative dose intensity (RDI) and survival in advanced PDAC. METHODS: In this multicenter prospective cohort, adults with locally advanced or metastatic PDAC planned for first-line chemotherapy underwent baseline nutritional and QoL assessments, including the Mini Nutritional Assessment (MNA), European Organisation for Research and Treatment of Cancer-Pancreas 26 (EORTC-PAN26), and Functional Assessment of Anorexia/Cachexia Therapy subscale (FAACT-A/CS). The primary outcome was chemotherapy delivery during the first 12 weeks, expressed as RDI. Secondary outcomes included overall survival (OS). Associations between baseline scores, RDI, and OS were analyzed using regression models adjusted for age, sex, disease stage, and center. Kaplan-Meier and Cox models assessed survival. RESULTS: Of 140 enrolled patients, 105 started chemotherapy. Malnutrition was frequent (55.7 % at risk, 33.6 % malnourished). Higher MNA and EORTC-PAN26 scores were associated with better RDI (r = 0.31, p = 0.001; r = 0.30, p = 0.002), whereas FAACT-A/CS showed no correlation. In multivariable analysis, higher MNA scores [odds ratio (OR) 0.55; 95 % confidence interval (CI) 0.32-0.96; p = 0.036] and metastatic disease (OR 0.36; 95 % CI 0.13-0.99; p = 0.048) independently predicted RDI ≥80 %. Reduced RDI (hazard ratio [HR] 2.05; 95 % CI 1.20-3.50; p = 0.009) and FAACT-A/CS < 28 (HR 1.90; 95 % CI 1.04-3.49) were independently associated with shorter OS. CONCLUSIONS: Baseline nutritional status and QoL, particularly assessed by MNA and EORTC-PAN26, predict chemotherapy delivery in advanced PDAC. Reduced RDI and anorexia/cachexia symptoms are linked to poorer survival, supporting systematic nutritional assessment and targeted interventions to optimize outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pancreatic, Biliary, and Upper GI Diseases, A.S. Loginov Moscow Clinical Research Center, Russia.
- Oncology Department, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute IRCCS, Milan, Italy.
- Gastroenterology Department, Bucharest Clinical Emergency Hospital, Romania.
- Gastroenterology Department, University Hospital of Puerta de Hierro de Madrid, Spain.
- Digestive Endoscopy Unit, University Hospital Center Dr Dragiša Mišović Dedinje, Belgrade, Serbia.
- Department of Gastroenterology, Dr. Balmis General University Hospital-ISABIAL, Alicante, Spain.
Förderung
- Ministry of Health
- Associazione Italiana per la Ricerca sul Cancro
Zitieren
APA
Kiriukova, M., Orsi, G., Sandru, V., de la Iglesia, D., Panic, N., Bozhychko, M., Avci, B., Burini, A., Cardellini, S., Loliva, V., Archibugi, L., Macchini, M., Panaitescu-Damian, A., Bordin, D., Arcidiacono, P. G., Maisonneuve, P., de-Madaria, E., Reni, M., & Capurso, G. (2026). Impact of nutritional status on chemotherapy delivery and outcomes in advanced pancreatic cancer: A prospective multicenter study. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2025.106573
Vancouver
Kiriukova M, Orsi G, Sandru V, de la Iglesia D, Panic N, Bozhychko M, et al. Impact of nutritional status on chemotherapy delivery and outcomes in advanced pancreatic cancer: A prospective multicenter study. Clinical Nutrition. 2026. doi:10.1016/j.clnu.2025.106573
BibTeX
@article{Kiriukova2026,
author = {Kiriukova, Maria and Orsi, Giulia and Sandru, Vasile and de la Iglesia, Daniel and Panic, Nikola and Bozhychko, Maryana and Avci, Bartu and Burini, Alice and Cardellini, Sara and Loliva, Valeria and Archibugi, Livia and Macchini, Marina and Panaitescu-Damian, Afrodita and Bordin, Dmitry and Arcidiacono, Paolo Giorgio and Maisonneuve, Patrick and de-Madaria, Enrique and Reni, Michele and Capurso, Gabriele},
title = {Impact of nutritional status on chemotherapy delivery and outcomes in advanced pancreatic cancer: A prospective multicenter study},
journal = {Clinical Nutrition},
year = {2026},
doi = {10.1016/j.clnu.2025.106573}
}
EUVIMED